Sangani Hospitals Limited IPO Message Board (Page 1)

sleep below 40/- is very dangerous zone

LC started

अगर इतना ही अच्छा stock होता तो LC नहीं लगता। जिनको बेचना था उसने बेच दिए।

A good positive listing of 10%. With low subscription and easy allotment, the gain is very good.
GMP shown in C G and negative views of some of the members, a good result. Some members were positive on listing. Difference of opinion between members on listing is always good.
Congratulations to all who got allotment and booked profits.

Very Good Return. 10000 to 12000 Profit in 1 Lot Allotment

What is script code?

SANGANI-ST

It Will list positive. It will give good return on easy allotment.

@Noorul sold 4 lots at average 43

Allotted 4 lots

0/5 in retail

Allotment OUT Now ✅

📷Check Here 📷
https://ipo.bigshareonline.com/IPO_Status.html

UPI Mandate accepted of 2 retails in the name of Unistone and QIB subscription... Hoping Allotment and good returns also...

Giving it a miss..

Applied few after seeing bumper response from QIB..

Applied few. 🤞

Applied 5 lots HNI

No inclination towards Sangani and Yudiz. Really very less discussion on these two

Again a Greedy Valuation with high PE.

Will SKIP

New bse sme

Shelter Pharma
10 to 14 aug
₹42
3000 lot
Lm Gretex

Retail is playing very dangerous game, oversubscribing every god damn IPO.
Here also 3.46 times already subscribed.
Hope these are sell and apply applicants and not open ones.
Applying in any random SME can lead to big losses recent examples. Bizotec, Cellpoint.

Hardly any GMP for sell and Apply kind of thing. Market is full of diverse thinking people.

MM- Rikhav Securities.
MUST AVOID

Company has 2 units with 68 bed combined and hospital segment revenue has dropped to 52% of total on YoY basis from 64%. On absolute basis, hospital segment revenue has grown 22% YoY
Keshod and Veraval are low population, tier 3 / 4 towns with individual population < 5 lacs. Nearest town, Junagadh, 38 kms away, has much better medical facilities. Not sure what is the targeted catchment area for the company.
CFO is related to promoter family. Including CFO, promoter salary has jumped from Rs 60 lacs to Rs 228 lacs. Whereas total PBT for 22-23 is Rs 201 lacs. Looks like promoters believe in taking cash and do not want to depend on dividends. Other shareholders to decide for themselves
YoY revenue has jumped by around 50% whereas receivables have remained same in absolute terms indicating prudent collection and receivable management.
PBT to CFOB4T conversion is decent in last 2 of the 3 fiscals.
YoY fixed assets jumped because of addition of buildings. Promoters have sold their owned property to the company and accepted shares in consideration.
YoY professional and consultancy fees jumped from Rs 47 lacs to Rs 151 lacs.
YoY implant, dialysis and lab consumables jumped from Rs 37 lacs to Rs 116 lacs.
Rs 4.49 cr cash and bank balances as on 31-Mar-23.
PF eligible staff dropped from 37 in Mar-22 to 14 in Jun-23, not sure if that is linked to increase in professional and consultancy expenses
Hands on promoters with 3 of them being qualified medical professionals
EBIDTA % has dropped from 29.84% in 21-22 to 20.08% in 22-23, mainly due to jump in promoters salaries
QIB portion kept at 10% of the IPO. Either LM is unsure of getting QIB quota filled or wants to show an illusion of high QIB subscription.
LM is known for giving surprise listing, as per past track record
Average revenue per bed per day is Rs 6313 and with EBIDTA of 20.08%, issue is priced at PE of 37 on post IPO capital
Asarfi Hospital, recent IPO, with ARPBPD of Rs 7750 and EBIDTA of 19.48% had post IPO PE of 13, at issue price.